AtriCure (ATRC) Income from Continuing Operations (2010 - 2026)
AtriCure (ATRC) posted quarterly Income from Continuing Operations of 8955000.0 for Q2 2026, up 244.67% year-over-year from 2598146.24 in Q2 2025, and up 8191.67% quarter-over-quarter from 108000.0 in Q1 2026.
AtriCure (ATRC) Income from Continuing Operations (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Income from Continuing Operations for 17 consecutive years, with 8955000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 244.67% year-over-year to 8955000.0; the TTM figure through Jun 2026 stood at 10552000.0 (up 129.02% YoY), while the FY2025 annual figure was 11448000.0, up 74.39% from the prior year.
- Income from Continuing Operations advanced to 8955000.0 in Q2 2026 per ATRC's latest filing, from 108000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 8955000.0 in Q2 2026 and bottomed at 15568000.0 in Q4 2024.
- Historically, Income from Continuing Operations has averaged 6888166.67 across 5 years, with a median of 7300000.0 in 2024.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations tumbled 134.75% — and 2026, when it soared 244.67%.
- AtriCure's Income from Continuing Operations stood at 4170000.0 in 2022, then sank by 134.75% to 9789000.0 in 2023, then sank by 59.04% to 15568000.0 in 2024, then surged by 111.28% to 1756000.0 in 2025, then surged by 409.97% to 8955000.0 in 2026.
- Business Quant data shows ATRC's Income from Continuing Operations at 8955000.0 in Q2 2026, 108000.0 in Q1 2026, and 1756000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | AtriCure | 2.39 Bn | 2.22 Bn | 118.63 Mn | 8.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.96 Mn |
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | -267,000.00 |
| Jun 30, 2025 | -6.19 Mn |
| Mar 31, 2025 | -6.75 Mn |
| Dec 31, 2024 | -15.57 Mn |
| Sep 30, 2024 | -7.85 Mn |
| Jun 30, 2024 | -8.01 Mn |
| Mar 31, 2024 | -13.27 Mn |
| Dec 31, 2023 | -9.79 Mn |
| Sep 30, 2023 | -9.06 Mn |
| Jun 30, 2023 | -5.12 Mn |
| Mar 31, 2023 | -6.48 Mn |
| Dec 31, 2022 | -4.17 Mn |
| Sep 30, 2022 | -12.27 Mn |
| Jun 30, 2022 | -14.84 Mn |
| Mar 31, 2022 | -15.18 Mn |
| Dec 31, 2021 | -13.74 Mn |
| Sep 30, 2021 | 97.11 Mn |